Download the FierceBiotech app for iPhone and iPad

FierceBiotech is now available on iPhone and iPad! Click here to download from the App Store.

This is the best FierceBiotech reading experience we've ever created. Swipe right-to-left within articles to quickly scan the latest news. Get breaking news alerts sent to your mobile device so you're the first to know when a major story unfolds. Download it today; the app is an essential complement to our e-mail newsletter and website. 

Android users: We're on track to have an app complete by the end of the year.

FierceBiotech is free for readers--and always will be thanks to the support of our advertising clients. Sponsorship inquiries for the mobile app should be sent to myself or Rebecca Friend (email), associate publisher of FierceBiotechAs always, let us know how we did and thanks for being part of the Fierce community! -- Arsalan Arif (email | Twitter)

FierceBiotech app

 

Suggested Articles

Spring Bank’s hepatitis B drug, given in tandem with Gilead’s Vemlidy, tamped down on chronic disease in 23% of patients in a phase 2 study.

Gilead names Dickinson to CFO role; MedImmune CSO Herbst nabs CSO job at Pyxis; Checkmate picks up Wooldridge for CMO.

The readout is a key moment in the history of the drug and Mirati, shares in which have soared in the updraft created by data on Amgen’s rival asset.